Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Halohydrin Formation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel halohydrin route for Entecavir intermediate N4 avoids hazardous epoxidation, offering safer scale-up and cost efficiency for antiviral manufacturing.
Patent CN1066728C reveals a robust 3-step route for epoxide intermediates, offering significant cost reduction in pharmaceutical manufacturing and improved supply chain reliability.